GPX4 and diffuse large B-cell lymphoma: In order to evaluate GPX4's prognostic role in DLBCL, KM curve also showed that there was a significant difference between patients' survival curves with low and high expression of GPX4, which was verified in TCGA data set (P < 0.05) (Fig. 3A–C).